Hofseth Biocare ASA
5.2.2021 12:16:12 CET | Globenewswire | Press release
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC"), has today purchased 70,000 shares in HBC at an average price of NOK 9.294 per share.
As a result of the transaction, Mr. Baldegger holds 650,000 shares in HBC, equal to 0.18 % of the outstanding shares.
This information is subject of the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Investeringsforeningen SDG Invest6.10.2026 09:20:47 CEST | Pressemeddelelse
Investeringsforeningen SDG Invest - prospekt ifbm med optagelse til handel af to afdelinger
Xometry, Inc.6.10.2026 09:05:00 CEST | Press release
Xometry Names Marc Teulières as General Manager for Europe to Accelerate Regional Adoption
Jeppesen ForeFlight6.10.2026 09:00:00 CEST | Press release
Jeppesen ForeFlight Airflow™ Agents Debut for Commercial Aviation, Centered on Operating Intelligence and Adoption Flexibility
Investeringsforeningen BankInvest6.10.2026 09:00:00 CEST | Pressemeddelelse
Ophævelse af suspension for andelsklasser under Investeringsforeningen BankInvest
Gabriel Holding A/S6.10.2026 08:25:47 CEST | Press release
Gabriel Holding A/S upwardly adjusts its expectations for the financial year 2025/26 for the continuing operations.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom